Balanites Aegyptiaca

Balanites aegyptiaca  (Linn.) Delile,

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym B. roxburghii Planch.
Family Simaroubaceae; Balanitaceae.
Habitat Drier parts of India, particularly in Rajasthan, Gujarat, Madhya Pradesh and Deccan.
English Desert Date.
Ayurvedic Ingudi, Angaar Vrksha, Taapasadrum, Taapasa vrksha, Dirghkantaka.
Unani Hingan, Hanguul.
Siddha / Tamil Nanjunda.
Folk Hingol, Hingota, Hingothaa.
Action Seed—expectorant, bechic. Oil—antibacterial, antifungal. Fruit—used in whooping cough; also in leucoderma and other skin diseases. Bark—spasmolytic.
Dosage Leaf, seed, bark, fruit— 50–100 ml decoction. (CCRAS.)
Taxonomic Cohort Genus Balanites (1 documented species); Family Simaroubaceae (6 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Balanites aegyptiaca (taxonomically cited with authority (Linn.) Delile,) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Simaroubaceae; Balanitaceae (primary family classification: Simaroubaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. roxburghii Planch, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Drier parts of India, particularly in Rajasthan, Gujarat, Madhya Pradesh and Deccan.

Across classical and vernacular Indian systems of medicine, Balanites aegyptiaca is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Desert Date; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Ingudi, Angaar Vrksha, Taapasadrum, Taapasa vrksha, Dirghkantaka; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Hingan, Hanguul; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Nanjunda; in regional Indian folk and vernacular ethnobotany as Hingol, Hingota, Hingothaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Balanites aegyptiaca are: Seed—expectorant, bechic. Oil—antibacterial, antifungal. Fruit—used in whooping cough; also in leucoderma and other skin diseases. Bark—spasmolytic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Balanites aegyptiaca establish the following evidence base: The plant is reported to be a potential source of diosgenin (used in oral contraceptives). The fruit pulp contains steroidal saponins. The diosgenin content of the fruit varies from 0.3 to 3.8%. Aqueous extract of fruits showed spermicidal activity without local vaginal irritation in human up to 4%; sperms became sluggish on contact with the plant extract and then became immobile within 30 s; the effect was concentration-related. Protracted administration of the fruit pulp extract produced hyperglycaemia-induced testicular dysfunction in dogs. An aqueous extract of mesocarp exhibited antidiabetic activity in streptozotocin-induced diabetes in mice. The seed contains balanitins, which exhibit cytostatic activity.

image2

Botanical Reference 1: Balanites aegyptiaca — Botanical specimen

image3

Botanical Reference 2: Balanites aegyptiaca — Botanical specimen

image3

Botanical Reference 3: Balanites aegyptiaca — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Balanites aegyptiaca stands as a distinct representative of the genus Balanites. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Simaroubaceae encompasses 6 documented medicinal species (0.33% of the 1,814-species flora). Other representative medicinal members of Simaroubaceae include: Ailanthus excelsa (Aralu), Ailanthus glandulosa (Aralu), Ailanthus malabarica (Guggul-dhuupa), Picrasma quassioides (Bhurangi), Quassia indica (Niepa Bark tree). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 6 medicinal species of family Simaroubaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Balanites aegyptiaca are prescribed as follows: Leaf, seed, bark, fruit— 50–100 ml decoction. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Balanites aegyptiaca integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top